Literature DB >> 22275491

Response to 'Orbital Wegener's granulomatosis as the initial presentation in a 9-year-old child'.

Elizabeth Meredith, Richard Hull.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22275491      PMCID： PMC3265232          DOI： 10.1258/jrsm.2011.110257

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Orbital Wegener's granulomatosis as the initial presentation in a 9-year-old child.

Authors:  Moloy Dey; Lola Lawyi; Roger S Wilson
Journal:  J R Soc Med       Date:  2011-08       Impact factor: 5.344

3.  Wegener's granulomatosis: studies in eighteen patients and a review of the literature.

Authors:  A S Fauci; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1973-11       Impact factor: 1.889

4.  Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Authors:  Kirsten de Groot; Lorraine Harper; David R W Jayne; Luis Felipe Flores Suarez; Gina Gregorini; Wolfgang L Gross; Rashid Luqmani; Charles D Pusey; Niels Rasmussen; Renato A Sinico; Vladimir Tesar; Philippe Vanhille; Kerstin Westman; Caroline O S Savage
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.